Abstract
Fabry disease is a genetic disorder caused by a deficiency of α-galactosidase A (GLA). In our previous studies, we structurally investigated Fabry disease using a structural analysis system, and revealed that structural changes in GLA are very important for understanding the molecular basis of this disease. To the best of our knowledge, there is no database including the structures of mutant GLAs. Herein, we constructed a database of clinical phenotypes, genotypes and structures of mutant GLAs. This database can be accessed as ‘fabry-database.org’, and is user friendly, being equipped with powerful computational tools. This database will help researchers and clinicians who study Fabry disease.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Desnick, R. J., Ioannou, Y. A. & Eng, C. M. Alpha-galactosidase A deficiency: Fabry disease, in The Metabolic and Molecular Bases of Inherited Disease 8th edn (eds Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 3733–3774 (McGraw-Hill, New York, NY, 2001).
Spada, M., Pagliardini, S., Yasuda, M., Tukel, T., Thiagarajan, G., Sakuraba, H. et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79, 31–40 (2006).
Hwu, W. L., Chien, Y. H., Lee, N. C., Chiang, S. C., Dobrovolny, R., Huang, A. C. et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum. Mutat. 30, 1397–1405 (2009).
Lee, B. H., Heo, S. H., Kim, G.- W., Park, J.- Y., Kim, W.- S., Kang, D H et al. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns. J. Hum. Genet. 55, 512–517 (2010).
Sugawara, K., Ohno, K., Saito, S. & Sakuraba, H. Structural characterization of mutant alpha-galactosidases causing Fabry disease. J. Hum. Genet. 53, 812–824 (2008).
Matsuzawa, F., Aikawa, S., Doi, H., Okumiya, T. & Sakuraba, H. Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes. Hum. Genet. 117, 317–328 (2005).
Acknowledgements
This work was supported by the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Saito, S., Ohno, K. & Sakuraba, H. Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease. J Hum Genet 56, 467–468 (2011). https://doi.org/10.1038/jhg.2011.31
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2011.31
Keywords
This article is cited by
-
What should rheumatologists know about Gaucher disease and Fabry disease? Connecting the dots for an overview
Advances in Rheumatology (2024)
-
The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants
Orphanet Journal of Rare Diseases (2023)
-
X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay
Clinical and Experimental Nephrology (2021)
-
Fabry disease screening in high-risk populations in Japan: a nationwide study
Orphanet Journal of Rare Diseases (2020)
-
Metabolomic Discovery of Novel Urinary Galabiosylceramide Analogs as Fabry Disease Biomarkers
Journal of the American Society for Mass Spectrometry (2015)
